Literature DB >> 3572399

The significance of homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations in human lumbar cerebrospinal fluid.

G Ebinger, Y Michotte, P Herregodts.   

Abstract

The concentrations of the acidic dopamine (DA) catabolites homovanillic acid (HVA) and 3,4-dihydroxyphenylacetic acid (DOPAC) measured in human CSF are supposed to reflect the "turnover" of DA in the brain. The notion of "turnover" is, however, not synonymous with impulse nerve activity in the dopaminergic systems. Significant amounts of DOPAC and HVA could, indeed, be demonstrated in brain structures wherein dopaminergic innervation has not been documented. It must also be noted that DA is not only a neurotransmitter itself, but also a precursor of norepinephrine and epinephrine. Furthermore, in lumbar CSF, levels of biogenic amine catabolites partially reflect metabolism in the spinal cord and may have limited relevance to neurotransmission in the brain. To elucidate these points further, we determined the concentrations of DOPAC and HVA in 22 areas of six human brains and eight levels of six human spinal cords. The data were correlated with the concentration of DA. Quantitative determinations were done using HPLC with electrochemical detection, after solvent and ion-pair extraction. In this study, significant amounts of both DOPAC and HVA were demonstrated in brain structures not previously associated with dopaminergic innervation. The relatively lower DA concentration in these structures suggests that in these regions, the DOPAC and HVA concentrations are unrelated to dopaminergic neurotransmission. The possible role of capillary walls and glial cells in the catabolism of DA must be further evaluated. The demonstration of DOPAC and HVA in the spinal cord is another argument against the hypothesis that CSF levels of HVA and DOPAC reflect closely the activity of the dopaminergic systems in the brain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572399     DOI: 10.1111/j.1471-4159.1987.tb05729.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Determinants of central sympathetic activation in spontaneous primary subarachnoid hemorrhage.

Authors:  Michael Moussouttas; Edwin W Lai; John Khoury; Thanh T Huynh; Keith Dombrowski; Karel Pacak
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

2.  CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy.

Authors:  Michael Moussouttas; Edwin W Lai; Keith Dombrowski; Thanh T Huynh; John Khoury; Gilberto Carmona; Matthew DeCaro; Karel Pacak
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

3.  Cerebrospinal fluid catecholamine levels as predictors of outcome in subarachnoid hemorrhage.

Authors:  Michael Moussouttas; Thanh T Huynh; John Khoury; Edwin W Lai; Keith Dombrowski; Scott Pello; Karel Pacak
Journal:  Cerebrovasc Dis       Date:  2012-01-05       Impact factor: 2.762

4.  Effects of clozapine on CSF homovanillic acid in spasmodic torticollis.

Authors:  A Thiel; D Dressler; A Reimer; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1994

Review 5.  Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia.

Authors:  H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Urinary excretions of 34 dietary polyphenols and their associations with lifestyle factors in the EPIC cohort study.

Authors:  Raul Zamora-Ros; David Achaintre; Joseph A Rothwell; Sabina Rinaldi; Nada Assi; Pietro Ferrari; Michael Leitzmann; Marie-Christine Boutron-Ruault; Guy Fagherazzi; Aurélie Auffret; Tilman Kühn; Verena Katzke; Heiner Boeing; Antonia Trichopoulou; Androniki Naska; Effie Vasilopoulou; Domenico Palli; Sara Grioni; Amalia Mattiello; Rosario Tumino; Fulvio Ricceri; Nadia Slimani; Isabelle Romieu; Augustin Scalbert
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

7.  Alzheimer Disease and Selected Risk Factors Disrupt a Co-regulation of Monoamine Oxidase-A/B in the Hippocampus, but Not in the Cortex.

Authors:  Maa O Quartey; Jennifer N K Nyarko; Paul R Pennington; Ryan M Heistad; Paula C Klassen; Glen B Baker; Darrell D Mousseau
Journal:  Front Neurosci       Date:  2018-06-26       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.